Jefferies Raises Price Target on Ceragon Networks (CRNT) to $2.50
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
Go back to Jefferies Raises Price Target on Ceragon Networks (CRNT) to $2.50
November 14, 2016 9:24 AM EST
Today's Pre-Open Stock Movers
Dynavax Technologies (Nasdaq: DVAX) 70.7% LOWER; announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) for HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for immunization of adults 18 years and older against hepatitis B infection. The FDA issues CRLs to communicate that the Agency has completed a review cycle of an application and to request additional information for review and approval. Dynavax expects a Class 2 designation for a... More
November 14, 2016 8:42 AM EST
Ceragon Networks (NASDAQ: CRNT) reported Q3 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $79.1 million versus the consensus estimate of $77.57 million.
For earnings history and earnings-related data on Ceragon Networks (CRNT) click here.
...
More
November 11, 2016 1:33 PM EST
The Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
AECOM Technology (NYSE: ACM) - consensus EPS $0.71
Abraxas Petroleum (Nasdaq: AXAS) - consensus loss $0.03
Akers Biosciences (Nasdaq: AKER) - no Street consensus
Aldeyra Therapeutics (Nasdaq: ALDX) - consensus loss $0.39
Amaya (NYSE: AYA) - consensus EPS $0.40
Asure Software (Nasdaq: ASUR) - consensus EPS... More
